Kurtis D. Davies - Concepedia

Author

Kurtis D. Davies

University of Colorado Anschutz Medical Campus ORCID

Also Known As

Jeremy P. Segal, Jones, Kenneth L., K Davies, K. D. Davies, K. Davies, K.D. Davies, Kurtis D. Davies, Kurtis D Davies, Kurtis D. Davies, Kurtis Davies

190

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Anschutz Medical Campus University of Colorado Denver Children's Hospital Colorado Morgan Adams Foundation Center for Cancer and Blood Disorders

About

Kurtis D. Davies is an author at University of Colorado Anschutz Medical Campus specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.9K
2	Social Sciences	2	2	209
3	Engineering	1	1	28
4	Health Sciences	1	1	21
5	Natural Sciences	1	1	13

Kurtis D. Davies

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Nature Medicine Oncogenic AgentPathologyCancer GeneticsMedicineLung Cancer	2013	582
Identifying and Targeting <i>ROS1</i> Gene Fusions in Non–Small Cell Lung Cancer Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Clinical Cancer Research	2012	454
Dual Mechanism of a Natural CaMKII Inhibitor Rebekah S. Vest, Kurtis D. Davies, Heather O’Leary, Molecular Biology of the Cell CytoskeletonCn21 Cell PenetratingCellular PhysiologySignaling PathwayDual Mechanism	2007	195
Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices Susan Goebel-Goody, Kurtis D. Davies, Rachel M.A. Linger, Neuroscience Synaptic PlasticityNeurophysiologyPhysiologyExtrasynaptic N-methyl-d-aspartate ReceptorsAdult Hippocampal Slices	2008	188
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer Jill J. Bastman, Hilary S. Serracino, Yuwen Zhu, The Journal of Clinical Endocrinology & Metabolism	2016	177
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors Jean M. Mulcahy Levy, Shadi Zahedi, Andrea M. Griesinger, eLife	2017	172
Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples Kurtis D. Davies, Anh‐Tuan Le, Jamie Sheren, Journal of Thoracic Oncology Molecular Diagnostic TechniquesMolecular Testing ModalitiesMedicineBioanalysisPathology	2018	162
DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Journal of Thoracic Oncology OncologyNucleic Acid BiomarkersCancer DetectionMedicinePathology	2019	148
Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer Kurtis D. Davies, Sakshi Mahale, David P. Astling, PLoS ONE Small Molecule InhibitorsSystems BiologyOncogenic AgentMedicineRos1 Inhibition Mediated	2013	135
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong, Nature	2024	117

Page 1